Lyme Disease: Pharmacist Prescribing of Chemoprophylaxis Treatment

Warning message

Please Log in to purchase access to this course.

Recorded: August 9, 2021

In response to rising Lyme disease incidence in Nova Scotia and the strain that post-tick exposure visits continue to place on the province’s emergency departments and walk-in clinics, the Nova Scotia College of Pharmacists Council has enabled pharmacist prescribing for Lyme disease chemoprophylaxis through an addition to the Standards of Practice: Prescribing Drugs, Appendix G – Prescribing for a Diagnosis Supported by a Protocol (see enclosed), effective August 1, 2021.

This program has been accredited for a maximum of 1.5 CEU’s by Continuing Pharmacy Education, College of Pharmacy, Dalhousie University.  File # CED-2021-288.  Accreditation Expires August 6th, 2022.

Speaker:  Dr. Todd Hatchette,  Professor; Dalhousie Department of Pathology and Laboratory Medicine; Chief, Division of Microbiology; Nova Scotia Health Authority

After attending this webinar, attendees will be able to: 
- reliably identify the tick as an adult or nymphal blacklegged tick; 
- estimate the duration of attachment based upon the extent of engorgement; 
- provide patients with information on tick removal; and 
- provide patients with information related to the evidence-based diagnosis and treatment of Lyme disease at both early and late stages
- educate patients on the topics as outlined by the Nova Scotia College of Pharmacists, Standards of Practice Prescribing